Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vadadustat switch study in hemodialysis patients with renal anemia
jRCTs051210090Completed
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of vadadustat in anemia of chronic kidney disease, sponsored by Mitsubishi Tanabe Pharma Corporation. Primary endpoint: Hemoglobin level at each point in the treatment period. Started Sep 2021; status: completed.
02
Drugs
vadadustat
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on jRCTs051210090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051210090.